412 related articles for article (PubMed ID: 19764835)
1. Socioeconomic differences in preferences and willingness-to-pay for insulin delivery systems in type 1 and type 2 diabetes.
Guimarães C; Marra CA; Colley L; Gill S; Simpson S; Meneilly G; Queiroz RH; Lynd LD
Diabetes Technol Ther; 2009 Sep; 11(9):567-73. PubMed ID: 19764835
[TBL] [Abstract][Full Text] [Related]
2. A valuation of patients' willingness-to-pay for insulin delivery in diabetes.
Guimarães C; Marra CA; Colley L; Gill S; Simpson SH; Meneilly GS; Queiroz RH; Lynd LD
Int J Technol Assess Health Care; 2009 Jul; 25(3):359-66. PubMed ID: 19619355
[TBL] [Abstract][Full Text] [Related]
3. Identifying factors that affect patients' willingness to pay for inhaled insulin.
Pinto SL; Holiday-Goodman M; Black CD; Lesch D
Res Social Adm Pharm; 2009 Sep; 5(3):253-61. PubMed ID: 19733826
[TBL] [Abstract][Full Text] [Related]
4. An evaluation of patients' willingness to trade symptom-free days for asthma-related treatment risks: a discrete choice experiment.
McTaggart-Cowan HM; Shi P; Fitzgerald JM; Anis AH; Kopec JA; Bai TR; Soon JA; Lynd LD
J Asthma; 2008 Oct; 45(8):630-8. PubMed ID: 18951253
[TBL] [Abstract][Full Text] [Related]
5. Willingness-to-pay stated preferences for 8 health-related quality-of-life domains in psoriatic arthritis: a pilot study.
Hu SW; Holt EW; Husni ME; Qureshi AA
Semin Arthritis Rheum; 2010 Apr; 39(5):384-97. PubMed ID: 19095293
[TBL] [Abstract][Full Text] [Related]
6. Patient preferences for depression treatment programs and willingness to pay for treatment.
Morey E; Thacher JA; Craighead WE
J Ment Health Policy Econ; 2007 Jun; 10(2):73-85. PubMed ID: 17603148
[TBL] [Abstract][Full Text] [Related]
7. Patients' value of asthma services in Australian pharmacies: the way ahead for asthma care.
Naik-Panvelkar P; Armour C; Rose J; Saini B
J Asthma; 2012 Apr; 49(3):310-6. PubMed ID: 22348432
[TBL] [Abstract][Full Text] [Related]
8. An evaluation of patient preference for an alternative insulin delivery system compared to standard vial and syringe.
Stockl K; Ory C; Vanderplas A; Nicklasson L; Lyness W; Cobden D; Chang E
Curr Med Res Opin; 2007 Jan; 23(1):133-46. PubMed ID: 17257475
[TBL] [Abstract][Full Text] [Related]
9. Willingness to pay to assess patient preferences for therapy in a Canadian setting.
Marra CA; Frighetto L; Goodfellow AF; Wai AO; Chase ML; Nicol RE; Leong CA; Tomlinson S; Ferreira BM; Jewesson PJ
BMC Health Serv Res; 2005 Jun; 5():43. PubMed ID: 15941474
[TBL] [Abstract][Full Text] [Related]
10. Preference for insulin delivery systems among current insulin users and nonusers.
Summers KH; Szeinbach SL; Lenox SM
Clin Ther; 2004 Sep; 26(9):1498-505. PubMed ID: 15531012
[TBL] [Abstract][Full Text] [Related]
11. Reliability of self-reported willingness-to-pay and annual income in patients treated for toenail onychomycosis.
Cham PM; Chen SC; Grill JP; Jonk YC; Warshaw EM
Br J Dermatol; 2007 May; 156(5):922-8. PubMed ID: 17459013
[TBL] [Abstract][Full Text] [Related]
12. [Costs of antihyperglycemic drugs and consumables and treatment satisfaction in patients with type 2 diabetes. Results of the health care research study LIVE-DE (long-acting insulin glargine compared with NPH insulin in Germany)].
Hauner H; Kohlmann T; Landgraf W; Holle R; Pirk O; Scholten T
Dtsch Med Wochenschr; 2009 Jun; 134(23):1207-13. PubMed ID: 19472091
[TBL] [Abstract][Full Text] [Related]
13. Use of willingness to pay to study values for pharmacotherapies for migraine headache.
Lenert LA
Med Care; 2003 Feb; 41(2):299-308. PubMed ID: 12555057
[TBL] [Abstract][Full Text] [Related]
14. Valuing the delivery of dental care: Heterogeneity in patients' preferences and willingness-to-pay for dental care attributes.
Sever I; Verbič M; Sever EK
J Dent; 2018 Feb; 69():93-101. PubMed ID: 29242040
[TBL] [Abstract][Full Text] [Related]
15. [Acceptance and understandability of various methods of health valuations for the chronically ill: willingness to pay, visual analogue scale and rating scale].
Meder M; Farin E
Gesundheitswesen; 2009 Nov; 71(11):e62-71. PubMed ID: 20094981
[TBL] [Abstract][Full Text] [Related]
16. A quantitative assessment of patient barriers to insulin.
Casciano R; Malangone E; Ramachandran A; Gagliardino JJ
Int J Clin Pract; 2011 Apr; 65(4):408-14. PubMed ID: 21401829
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of inhaled insulin in the treatment of diabetes mellitus.
de Galan BE; Simsek S; Tack CJ; Heine RJ
Neth J Med; 2006 Oct; 64(9):319-25. PubMed ID: 17057268
[TBL] [Abstract][Full Text] [Related]
18. Valuing a hypothetical cure for rheumatoid arthritis using the contingent valuation methodology: the patient perspective.
Fautrel B; Clarke AE; Guillemin F; Adam V; St-Pierre Y; Panaritis T; Fortin PR; Menard HA; Donaldson C; Penrod JR
J Rheumatol; 2005 Mar; 32(3):443-53. PubMed ID: 15742435
[TBL] [Abstract][Full Text] [Related]
19. An assessment of the burden of migraine using the willingness to pay model.
Hamelsky SW; Lipton RB; Stewart WF
Cephalalgia; 2005 Feb; 25(2):87-100. PubMed ID: 15658945
[TBL] [Abstract][Full Text] [Related]
20. Preferences for improvements in attributes associated with basal insulin: a time trade-off and willingness-to-pay survey of a diabetic and non-diabetic population in Sweden.
Olofsson S; Norrlid H; Persson U
J Med Econ; 2016 Oct; 19(10):945-58. PubMed ID: 27149402
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
